Epocrates vs Schrödinger
Epocrates and Schrödinger both compete in drug info, but answer different questions. Epocrates is our pick for clinician drug app: Most-used clinician drug-reference app in the US, free tier. Schrödinger earns the drug-discovery platform slot: Physics-based simulation + ML. Used by most top-20 pharma. The right choice depends on whether your priority is clinician drug app or drug-discovery platform.
- Drug info
- 02
- May 23, 2026
Epocrates
by Epocrates (athenahealth/Bain) · founded 1998
Most-used clinician drug-reference app in the US.
- Free + $16.99/mo Plus + $159/yr Essentials.
- —
Schrödinger
by Schrödinger Inc.
Physics-based molecular simulation + ML platform.
- Enterprise software + co-development.
- —
How Epocrates and Schrödinger compare
Pricing, compliance, and integrations sourced from vendor documentation. Verified May 23, 2026.
| Spec | Epocrates | Schrödinger |
|---|---|---|
| Pricing | Free + $16.99/mo Plus + $159/yr Essentials. | Enterprise software + co-development. |
| Free tier | Yes | Yes |
| HIPAA | No / unverified | No / unverified |
| SOC 2 Type II | No / unverified | No / unverified |
| EHR integrations | Not specified | Not specified |
| Founded | 1998 | — |
| HQ | US | US |
| Best for | Best free clinician drug app | Best AI drug-discovery platform |
Scroll horizontally to see both columns.
When to pick each one
Best free clinician drug app
Most-used clinician drug-reference app in the US, free tier.
- Free + $16.99/mo Plus + $159/yr Essentials
- Pill ID, formulary, interactions
Best AI drug-discovery platform
Physics-based simulation + ML. Used by most top-20 pharma.
- NASDAQ:SDGR
- Enterprise software + co-development model
- Different audience from clinicians
Open the full drug info comparison
Drug references (Lexidrug, Micromedex, Epocrates), interaction checkers, and emerging AI drug-discovery platforms (Insilico, Schrödinger, Recursion). Two distinct markets covered.
/best-ai-drug-information